PrognoCIS References Capped?

Access even more references from these marketplace competitors

  • 4.8 / 5.0 (3288)
    Sponsored76+ References
  • 4.7 / 5.0 (4611)
    Verified377+ References
  • 4.7 / 5.0 (5465)
    Verified448+ References

PrognoCIS

Verified
Read 22 PrognoCIS reviews and testimonials from customers, explore 6 case studies and customer success stories, and watch 3 customer videos to see why companies chose PrognoCIS as their Health Care

One of the very early providers of EPCS, PrognoCIS enables users to seamlessly and securely transmit e-prescriptions to pharmacies for DEA class I, II, III, IV, and V. The feature enforces two-factor authentication for prescription of narcotic drugs to ensure that drugs are not prescribed by unauthorized employees like medical assistants, nurses or administrative staff. PrognoCIS, as well as Surescripts®, keeps track of every prescription for auditing purposes. It then makes those prescriptions available as part of a patient’s medication history, regardless of where and by whom the prescription was given.

Show more
Category:
Customer Rating Review Scorebased on 2481 reference ratings
4.7/5.0 (2481)

22Testimonials

  • “The value proposition for [telemedicine] is the ability to expand their geographic reach, take on more lives, treat patients simply and affordably through telemedicine, but when things are more complex, you can filter them back into your hospital system.There’s also the cost savings to treating people where they are rather than at a hospital.”

21 more testimonialscurrently locked

6 Case Studies

  • Dial PrognoCIS for Payments that Ring with Integrity

5 more case studiescurrently locked

3 Customer Videos

2 more videoscurrently locked

Additional PrognoCIS Information & Resources

Read PrognoCIS Reviews, Testimonials & Customer References from 22 real PrognoCIS customers.

Browse PrognoCIS Case Studies, Customer Success Stories, & Customer References from 6 businesses that use PrognoCIS.

Watch PrognoCIS Customer Videos to learn why 3 businesses chose PrognoCIS.